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Abstract
Notch is required for many aspects of cell fate specification and morphogenesis during development, including neurogenesis and axon
guidance. We here provide genetic and biochemical evidence that Notch directs axon growth and guidance in Drosophila via a “non-canonical”,
i.e. non-Su(H)-mediated, signaling pathway, characterized by association with the adaptor protein, Disabled, and Trio, an accessory factor of the
Abl tyrosine kinase. We find that forms of Notch lacking the binding sites for its canonical effector, Su(H), are nearly inactive for the cell fate
function of the receptor, but largely or fully active in axon patterning. Conversely, deletion from Notch of the binding site for Disabled impairs its
action in axon patterning without disturbing cell fate control. Finally, we show by co-immunoprecipitation that Notch protein is physically
associated in vivo with both Disabled and Trio. Together, these data provide evidence for an alternate Notch signaling pathway that mediates a
postmitotic, morphogenetic function of the receptor.
© 2007 Elsevier Inc. All rights reserved.Keywords: Notch; Signal transduction; Non-canonical signalling; Abl; Disabled; Trio; Axon guidance; CSLIntroduction
We have come to appreciate that a small handful of
ubiquitous, highly conserved signal transduction pathways
together account for a remarkable fraction of the patterning of a
developing animal. In different tissues, Hedgehogs, Wnts,
TGFβs, receptor tyrosine kinases and a few other key signaling
modules specify cell identities, set developmental boundaries,
direct cell migration and shape tissue morphogenesis (Gerhart
and Kirschner, 1997; Ptashne and Gann, 2002). In each case,
however, it remains mysterious how a single signal can produce
such varied effects. In the case of Wnt signaling, some of the
diversity of biological readouts seems to arise from the
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doi:10.1016/j.ydbio.2007.10.030the “canonical” β-catenin pathway and at least two “non-
canonical” signaling mechanisms (Boutros et al., 1998; Kuhl et
al., 2000; Pandur et al., 2002; Yoshikawa et al., 2003).
Presumably, this diversity of signaling pathways is used, in
various combinations, to elicit different cellular outcomes in
response to an input Wnt signal. Multiple signaling pathways
have also been described downstream of other receptor families,
such as the receptor tyrosine kinases (Fantl et al., 1992).
The receptor Notch, together with its ligands, Delta and
Serrate, define another of these common, multipotent develop-
mental signaling pathways (Artavanis-Tsakonis et al., 1999;
Frisen and Lendahl, 2001). First studied in Drosophila, Notch
orthologs have been found in nearly all metazoan phyla, where
they define the boundaries of developmental compartments,
distinguish the developmental potentials of sibling cells and
limit the segregation of differentiated cells from among fields of
equipotent progenitors. A conserved signaling mechanism has
been described for Notch proteins, whereby ligand activation
causes Notch to be cleaved proteolytically at the inner edge of
the plasma membrane, releasing an intracellular fragment that
transits to the nucleus to form a transcription control complex in
association with at least two cofactors, the DNA-binding protein
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transcriptional co-activator Mastermind (Mam) (Artavanis-
Tsakonis et al., 1995; Hansson et al., 2004; Jeffries et al.,
2002; Petcherski and Kimble, 2000).
Over the past several years, however, experiments in a variety
of vertebrate and invertebrate systems have hinted at the
existence of a “non-canonical”, Su(H)-independent, signaling
pathway for Notch (Brennan and Gardner, 2002; Ordentlich et
al., 1998; Ramain et al., 2001; Shawber et al., 1996; Wang et al.,
1997; Zecchini et al., 1999). In Drosophila, for example, it
seems that a Su(H)-independent Notch activity regulates the
morphogenetic movements of dorsal closure (Zecchini et al.,
1999), while in vertebrates, CSL-independent Notch signaling
appears to blockmuscle differentiation ofmyoblasts (Shawber et
al., 1996), inhibit transcriptional activation by E-proteins (E47)
in B-cells (Ordentlich et al., 1998) and promote survival of
neural stem cells and embryonic stem cells (Androutsellis-
Theotokis et al., 2006). While these studies have been
suggestive, however, it has been difficult to test thoroughly the
notion of a non-canonical Notch signaling pathway since inmost
cases the molecular properties of the postulated alternate
pathway have not been clearly defined.
Non-canonical Notch signaling has also been invoked in
axon guidance in Drosophila (Crowner et al., 2003; Giniger,
1998), and we have suggested that the Abl tyrosine kinase and its
associated signaling pathway provides a good candidate for an
alternate Notch signaling mechanism. This hypothesis was
based upon two major findings, that Notch interacts genetically
with gain- and loss-of-function manipulations of abl and its
cofactors to direct the growth of particular axons, and that a
protein interaction domain of one postulated Abl accessory
factor, the adaptor protein Disabled (Dab), can bind directly to
Notch in vitro. A link between Notch and Abl is of interest not
just because of its implications for Notch, but also for the light it
might shed on Abl signaling. Abl is a cytoplasmic tyrosine
kinase that has been studied for more than two decades as one of
the first cellular genes clearly implicated in the etiology of a
common human cancer (Druker et al., 2001; Fainstein et al.,
1987; Goff et al., 1980). Moreover, a central role for Abl in axon
patterning has been solidly established by extensive genetic
experiments, particularly in Drosophila (Hoffmann, 1991).
Here, Abl contributes to the growth and guidance of many, if
not most, developing axons, apparently by locally controlling
actin organization and dynamics (Baum and Perrimon, 2001;
Bear et al., 2000; Gertler et al., 1989; Grevengoed et al., 2001;
Luo, 2000; Wills et al., 1999).
Abl performs its functions in cooperation with a constella-
tion of conserved accessory proteins. Three cooperating factors
were originally identified in Drosophila as genetic loci that
enhance the phenotype of an abl mutant. These were trio,
which encodes a guanine nucleotide exchange factor (GEF) for
Rho GTPases, fax, encoding a protein found in axon bundles,
and neurotactin (nrt), encoding a cell-surface adhesion protein
(Gertler et al., 1993; Hill et al., 1995; Hortsch et al., 1990; Liebl
et al., 2000, 2003). An additional putative cooperating factor,
disabled (dab), was originally identified as a multicopy
suppressor of both fax abl and abl nrt mutant combinations(Gertler et al., 1993; Liebl et al., 2003). In addition to these
cooperating factors, Abl works in concert with a specific
antagonist, the signaling protein Enabled (Ena; Gertler et al.,
1995). Despite intensive study, however, to date it has been
difficult to discern the detailed mechanism by which Abl
pathway proteins guide axon growth. For example, there have
been only a handful of cases where it has been possible to
demonstrate physical association of Abl pathway effector
proteins with growth cone receptors in vivo, and to correlate
those associations with specific axon patterning decisions
(Bashaw et al., 2000; Forsthoefel et al., 2005).
We present here genetic, molecular and biochemical evidence
for a non-canonical, i.e. non-Su(H) mediated, Notch signaling
pathway employing Abl signaling components to promote axon
growth and guidance in Drosophila. We prepare Notch
derivatives that are inactive for the Su(H)-dependent cell fate
function of Notch but find that they nonetheless are largely or
fully active for promoting Notch-dependent axon patterning,
while conversely, removing the binding site on Notch for
Disabled impairs axon patterning without affecting cell fate
control. We also show that Notch co-immunoprecipitates from
wild type fly lysates in association with Disabled, and with the
Abl pathway effector, Trio. Together, these data suggest a
molecular basis for the genetic interaction of Notch and Abl that
promotes embryonic axon patterning in Drosophila, as well as
providing reagents and diagnostic properties that can be used to
identify the contribution of this pathway at other times and
places in development.
Results
Notch domains required for axon patterning
Previous experiments have shown that inactivatingNotchwith
a temperature-sensitive mutation (Notchts1) shortly before CNS
longitudinal axon tracts are pioneered in the developing fly
embryo yields a ‘disconnected’ phenotype in which axons fail to
grow between segments of the ventral nerve cord, and those axons
can be restored by expressing a wild type Notch transgene in
postmitotic neurons (Figs. 1B–H, quantified in Fig. 1N; Giniger,
1998; Giniger et al., 1993). We therefore expressed a series of
modified Notch transgenes in the Notchts1 background to map
domains that are required for axonal function of the protein. The
same derivatives were also tested for their ability to perform
“lateral inhibition”, the classic Notch cell fate function that limits
the number of neurons in the embryo, and whose absence
produces the severe neural hyperplasia characteristic of strong
Notch alleles (known as the “neurogenic phenotype” (Lehmann
et al., 1983), Figs. 1I–M; (Le Gall and Giniger, 2004)).
Deletion of the binding region for the ligands Delta and
Serrate (EGF repeats 10-12; Lieber et al., 1993; Rebay et al.,
1991) from the Notch extracellular domain completely ablated
the ability of a Notch transgene to restore axon patterning (Fig.
1G; quantification in panel N), consistent with prior experi-
ments showing that a Delta mutation produces the same axonal
defects as does a Notch mutation (Crowner et al., 2003; Giniger
et al., 1993). Intracellular sequences of Notch were also
Fig. 1. Identification of domains of Notch protein required for axon patterning. (A) Schematic representation of Notch protein, and of derivatives used below. Functional
domains are drawn approximately to scale. LNR: Lin12/Notch repeats, TM: transmembrane domain, cdc10: ankyrin/cdc10 repeat domain. Asterisks in the block
diagram indicate positions of Su(H) binding sites. Thick lines represent protein coding sequences present in the indicated transgenes. (B–M) Embryos of the indicated
genotypes were raised to embryonic stage 16/17 either at 25 °C (I–M) or by an appropriate temperature-shift regimen (B–H), fixed, incubated with anti-Fasciclin 2 to
label particular axon tracts (B–H) or with anti-Elav to label neuronal nuclei (I–M) and visualized with peroxidase histochemistry. Experiments to assay axon patterning
(C–H) employed the alleleNotchts1 and used the temperature protocol described in Giniger (1998); experiments assaying lateral inhibition (J–M) employedNotch55e11.
For rescue of axonal phenotypes (D–H) Notch transgene was under control of elav-GAL4; for rescue of neurogenic phenotypes (K–M) Notch transgenes were
expressed under control of sca-GAL4. (B, I) wild type embryos; (C, J) Notch− (Notchts1 and Notch55e11, respectively); (D, K) Notch−; UAS-Notchwt; (E, L) Notch−;
UAS-NotchΔcdc10. While this transgene gave some rescue of longitudinal axons (see quantification in panel N), rescue was incomplete and often restored
intersegmental connection of only a single fascicle (arrowhead); (F, M) Notch−; UAS-NotchΔ2155; (G) Notchts; UAS-NotchΔEGF10–12. Expression of this transgene
consistently produced more severe axonal defects than those observed in the parent Notchts1 stock, suggesting a dominant inhibitory activity. (H) Notchts;
UAS-NotchECN. Experiments published by others have documented previously that NotchECN and NotchΔ10–12 lack all function in lateral inhibition (Jacobsen et al.,
1998; Lieber et al., 1993). Arrows in panels C and H highlight breaks in longitudinal axon tracts. Anterior is to the left in all panels; dorsal is to the top in panels I–M.
(N) Histogram quantifying the fraction of missing CNS longitudinal connections observed in the experiments of panels C–H. As described in the Experimental
procedures, the number of broken connections between successive thoracic and abdominal hemisegments was counted, and expressed as a percentage of the total.
Expression of NotchΔ10–12 consistently produced more disconnections than the Notchts1 control. Average variation in the percentage of disconnected hemisegments for
a given genotype in different experiments was ±5%. NN400 hemisegments for all genotypes except Notchts1; UAS-NotchΔ10–12, for which approximately 50% of
embryos had a disrupted morphology due to the antimorphic effect of the transgene, and were excluded from the quantification.
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the entire intracellular domain (NotchECN; Jacobsen et al., 1998)
was devoid of axonal activity (Fig. 1H).
Deletion of a portion of the intracellular domain comprising
the ankyrin/cdc10 repeats and the C-terminal portion of the Ram
domain (NotchΔcdc10) reduced axonal activity of Notchsignificantly, however, to our surprise substantial axonal activity
remained (Figs. 1E, N; comparison to Notchts gives P≪0.001;
χ2). This is in contrast to the complete failure of this protein to
suppress the neural hyperplasia of a strong Notch mutant (Fig.
1L, similar to the Notch null embryo in 1J), or to activate
expression of canonical Notch target genes (reviewed in Le Gall
559M. Le Gall et al. / Developmental Biology 313 (2008) 556–567and Giniger, 2004). Remarkably, moreover, a Notch derivative
truncated at the C-terminal end of the ankyrin repeat region,
NotchΔ2155 (Wesley and Saez, 2000), was nearly wild type for
Notch axonal function, even though it, too, was completely
inactive for suppressing the Notch “neurogenic” phenotype
(Figs. 1F, M) and has been shown previously to be incapable of
activating expression of the Notch target gene, E(spl) (Wesley
and Saez, 2000). These data begin to suggest that the sequence
requirements for Notch function in axon patterning may be
different from those required for the canonical cell fate
functions of the protein.
The Disabled binding site on Notch is required for full axonal
function of Notch, while the Su(H) sites are largely dispensable
Abl tyrosine kinase has been implicated genetically in the
mechanism by which Notch controls axon patterning, and one
postulated Abl accessory protein, the adaptor protein Disabled,
binds in vitro to a small region in the juxtamembrane portion of
the Notch intracellular domain (Giniger, 1998; Le Gall and
Giniger, 2004). We therefore wondered whether the axon
patterning activity of Notch might depend, in part, on the
Disabled binding site, which is still present in both NotchΔcdc10
and NotchΔ2155. As above, modified Notch transgenes were
assayed for their ability to restore axon patterning in Notchts1
embryos and to suppress neural hyperplasia in embryos
hemizygous for the strong allele, Notch55e11 (Giniger, 1998;
Le Gall and Giniger, 2004).
Deletion of Su(H) binding sites of Notch had only limited
effect on axon patterning despite ablating almost completely the
ability of Notch to limit neurogenesis, while deletion of the
Disabled site impaired axonal function with little or no effect on
neurogenesis (Fig. 2). A derivative of full-length Notch deleted
for the Disabled binding site, NotchΔRamA, was impaired by
about 30% relative to the wild type protein in its ability to
restore longitudinal growth of CNS axons when expressed in
Notchts1 (Fig. 2B, quantified in I; P≪0.001 (χ2)). The
minimal deletion we have so far identified that prevents
Disabled binding also deletes the amino-terminal Su(H)
binding site, thus, NotchΔRamA has a slight deficit in lateral
inhibition (Fig. 2F; quantified in J). However, a Notch protein
bearing a missense mutation that inactivates just that Su(H)
site (NotchRam∗; Le Gall and Giniger, 2004) has an identical
deficit in neurogenesis (Fig. 2G; PN0.5, ANOVA) but is nearly
wild type for axon patterning (Figs. 2C, I), suggesting that the
axonal phenotype of NotchΔRamA is not due to the absence of
this Su(H) binding site. Indeed, even a Notch derivative lacking
all three Su(H) binding sites (NotchRam∗Δ3) retains signifi-
cantly more axon patterning activity than does NotchΔRamA
(Fig. 2D, Pb0.01; χ2), even though NotchRam∗Δ3 is almost
completely inactive in suppressing neural hyperplasia (Fig. 2H;
compare with the level of neural hyperplasia in dorsal portions
of the Notch mutant embryo in Fig. 1J, and see also (Le Gall
and Giniger, 2004)), whereas NotchΔRamA is only mildly
impaired. (Note that the efficacy of the NotchRam∗, NotchΔRamA
and NotchRam∗Δ3 mutations for blocking Su(H) binding to
Notch has been documented previously; Le Gall and Giniger,2004.) We wished to be certain that the differential rescue of
axonal versus cell fate phenotypes by these Notch derivatives
reflected the differing requirements of the two biological
processes and not peculiar properties of the Notchts1 protein.
In separate experiments, therefore, we also induced neurogenic
defects by early temperature shifts of Notchts1 and confirmed
that they displayed the same pattern of rescue by various Notch
derivatives as did the neurogenic defects of Notch55e11 (data not
shown). We therefore infer (1) that the ability of Notch to
control axon patterning cannot be accounted for by its binding
sites for Su(H), (2) that the Disabled site, and not the Su(H) site,
within the ΔA deletion is likely to be responsible for the axonal
deficit of NotchΔRamA protein, and (3) that the Disabled site
does not contribute substantially to the neurogenic function of
Notch.
Similar results were obtained from assay of a second Notch-
dependent axon guidance decision. An appropriate temperature
shift of Notchts embryos blocks defasciculation of ISNb motor
axons from the intersegmental nerve (ISN) at the first peripheral
choice point (Crowner et al., 2003; shown schematically in Fig.
3A). Since this is a relatively late event in embryogenesis, the
temperature shift does not perturb CNS development, simplify-
ing the phenotypic analysis and facilitating precise quantifica-
tion. A Notch transgene lacking just the Ram Su(H) site or all
three Su(H) sites rescued axon patterning as well as did a wild
type Notch transgene (Fig. 3B; 8% of hemisegments showing
residual axonal defects in embryos rescued with NotchRam∗ and
7% with NotchRam∗Δ3, vs. 6% for wild type Notch; difference
not significant). In contrast, the transgene lacking the Disabled
binding site is significantly impaired in axonal activity, with
rescue reduced by ∼40% compared to wild type (Pb0.01;
ANOVA).
As an alternate way to assess the role of canonical Notch
signaling in axon patterning we examined expression of the
known Notch target gene, E(spl)mδ, in cells that are executing
Notch-dependent guidance processes. Previous experiments
have shown that neuronal Notch activity is required for
extension of the axons of the longitudinal pioneers dMP2 and
vMP2, and for defasciculation of the ISNb pioneer RP3
(Giniger, 1998; Crowner et al., 2003). Examination of an E
(spl)mδ-lacZ reporter gene (Cooper and Bray, 1999), however,
fails to reveal any evidence for lacZ expression in these
pioneer neurons, or in surrounding neurons, at the time these
Notch-dependent axon guidance events are occurring (Fig. 4).
These data should be interpreted cautiously, of course, since
even the most general Notch target genes are not used in all
Notch-dependent processes, however, this observation is
consistent with the idea that activation of Notch signaling
for guidance of CNS longitudinal pioneers and ISNb
motoneurons may not be associated with activation of the
canonical effector pathway.
Data above suggest that the Disabled binding site on Notch is
required for Notch-dependent axon patterning, a process
mediated by the genetic interaction of Notch with genes of
the Abl signaling pathway. The role of Disabled in Abl
signaling, however, remains controversial due to the lack of any
disabled mutants with which to assess the loss of function
Fig. 2. Roles of Su(H) binding sites and Disabled binding site in Notch-dependent lateral inhibition and CNS axon growth. Embryos of the indicated genotypes were
prepared as for the experiment of Fig. 1, except that the temperature shift protocol was refined to allow more precise quantification (see Experimental procedures). A
schematic of the Notch derivatives used in this experiment is included at the top of the figure; brown asterisks (∗) designate Su(H) binding sites; ‘X’ designates a
missense mutation that prevents binding of Su(H) to its amino-terminal binding site; purple (#) indicates the Disabled binding site. (A–D) dorsal views of the CNS in
embryos that are Notchts1 and carry elav-GAL4; (E–H) lateral views of the dorsal and lateral clusters of sensory neurons in four successive segments of embryos that
are Notch55e11 and carry sca-GAL4. For comparison, panel E′ is a lower magnification view of the embryo in panel E, with a box indicating the portion included in the
high-magnification panel. The UAS-Notch transgene is indicated to the left of each pair of images (A, E) Notch−; UAS-NotchWT; (B, F) Notch−; UAS-NotchRamΔA;
(C, G) Notch−; UAS-NotchRam∗; (D, H) Notch−; UAS-NotchRam∗Δ3. NotchRam∗Δ3 is a full-length Notch transgene specifically deleted for all three Su(H) binding
sites, NotchRam∗ bears a missense mutation inactivating just the Su(H) binding site in the Ram domain, NotchΔRamA bears a deletion of the first 35 codons of the
Ram domain, thus removing both the Su(H) site and the in vitro Disabled binding site in this domain. NotchRam∗Δ3 and NotchRam∗ are described in Le Gall and
Giniger (2004). Arrows in panel B highlight interruptions of the longitudinal axon tracts. (I) Histogram quantifying the percent rescue of defective longitudinal
connections between hemisegments for the experiment of panels A–D. Rescue by full-length, wild type Notch was defined as 100%. Average variation in the
percentage of disconnected hemisegments for a given genotype in different experiments was ±2%. P-values (χ2) for selected key comparisons are indicated:
∗∗Pb0.01; ∗∗∗P≪0.001. NN500 hemisegments for all genotypes. (J) Histogram quantifying the number of dorsal sensory neurons per hemisegment in Notch55e11
embryos rescued with the indicated Notch transgene for the experiment of panels E–H. For all genotypes, SEMb1.0 neuron (thin horizontal lines), and NN35
hemisegments. (K) Immunoblot of total lysate of wild type embryos (lane 1) or embryos expressing the indicated Notch derivative under control of elav-GAL4 (lanes
2–5). Top: anti-Notch immunostaining. Bottom: anti-β-tubulin loading control.
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Fig. 3. Activity of Notch derivatives in turning of ISNb motor axons. (A)
Schematic of the ISNb motor nerve. Wild type ISNb motor axons
defasciculate from the main ISN trunk upon contact with Delta-expressing
cells at the choice point; inactivation of Notch with a temperature-sensitive
mutation prevents defasciculation. Numbered ovals represent muscles along
the ISNb path and in its target field. (B) Embryos of the indicated genotype
were subjected to a temperature-shift protocol that produces a partial failure
of ISNb defasciculation. Embryos were fixed, immunostained with anti-
Fasciclin 2 antibody to label motoneurons and visualized by peroxidase
histochemistry. The fraction of hemisegments in which some or all ISNb
motor axons failed to turn at the choice point was quantified in filet
preparations and is indicated by the horizontal bars. Thin lines indicate SEM.
In all cases, expression of the indicated transgene was driven with elav-GAL4.
The degree of rescue of the mutant phenotype was not significantly different
among UAS-NotchWT, UAS-NotchRam∗ and UAS-NotchRam∗Δ3; rescue by
UAS-NotchRamΔA was significantly impaired (∼40% reduced; Pb0.01
(ANOVA)).
561M. Le Gall et al. / Developmental Biology 313 (2008) 556–567phenotype of the gene (Liebl et al., 2003). To further test the
role of Disabled in Notch/Abl-dependent axon patterning we
therefore assayed the effect of Disabled overexpression on
defasciculation of ISNb (Fig. 5). In a wild type genetic
background, overexpression of Disabled had no effect on
ISNb defasciculation at the first choice point (bypass of the
choice point observed in 3±1% of hemisegments, the same as
in wild type embryos subjected to the temperature shift protocol
(Crowner et al., 2003; Wills et al., 1999)). However, Disabled
overexpression substantially enhanced the Notch mutant
phenotype (42±0.3% bypass in Notchts; elav-GAL4; UAS-
Disabled, vs. 32±0.7% in the Notchts internal control embryos;
P≪0.01, ANOVA). This synergistic interaction of Notch withDisabled mimics the interaction of Notch with other manipula-
tions that enhance signaling in the Abl pathway, including
overexpression of Abl or heterozygous mutation of the Abl
antagonist, enabled (Crowner et al., 2003), consistent with the
hypothesis that Disabled modulates Abl pathway signaling in
vivo.
Co-immunoprecipitation of Notch with Disabled and Trio
In support of the genetic data described above, biochemical
experiments showed that Notch co-immunoprecipitates from
wild type Drosophila lysates with Disabled, and also with the
Abl accessory protein, Trio. In the case of Disabled, Western
blotting of anti-Disabled immunoprecipitates revealed the
presence of full-length Notch (Fig. 6). Four lines of evidence
suggest that the association of Notch with Disabled is authentic
and specific. First, three different anti-Disabled antibodies co-
precipitated Notch. These included two independent polyclonal
antibodies (one is shown in Fig. 6A, lane 4, middle panel), as
well as a monoclonal antibody (Fig. 6B, lane 4; characterization
of anti-Disabled antibodies is documented in Supplementary
Fig. S-1). Second, association was detected in two different wild
type fly lysates, a total embryo lysate (Fig. 6B) and a lysate
made from adult heads (Fig. 6A). Third, immunoprecipitations
performed in parallel with two irrelevant mouse IgGs (anti-Islet,
or normal mouse IgG) did not co-precipitate detectable Notch
protein (Fig. 6A, lane 5, middle panel; Fig. 6B, lane 3; Fig. 6C,
lane 3; data not shown). Fourth, immunoprecipitation of
Disabled from extracts of Notch-overexpressing animals co-
precipitated more Notch protein than did immunoprecipitation
from wild type extracts done in parallel. We have not been able
to test for the presence of Disabled in anti-Notch immunopre-
cipitates since the current anti-Disabled antibodies, while
specific, are not sufficiently sensitive in Western blots (Fig.
6A, bottom panel).
Multiple lines of evidence also demonstrate association of
Notch with Trio in wild type fly extracts. Immunoprecipitations
with anti-Notch caused co-precipitation of Trio, again, both
from adult head lysates (Fig. 6A, lane 3, top panel) and from
wild type embryo lysates (not shown). We also reversed the
experiment and found that immunoprecipitation of Trio caused
co-precipitation of full-length Notch (Fig. 6C, lane 4). Finally,
side-by-side co-immunoprecipitations of extracts from wild
type and Notch-overexpressing animals detected more Notch
co-precipitated with anti-Trio in the overexpressing lysates
(Supplementary Information, Fig. S-2, compare lanes 3, 4), as
well as detecting more Trio in anti-Notch immunoprecipitates
from these extracts (not shown). Together, these data show that
Notch is found in complexes with both Disabled and Trio in
extract of wild type flies. Our data do not prove whether Notch
associates with Disabled and Trio simultaneously or whether
these two proteins form separate complexes with Notch,
however, we note that immunoprecipitations with any of three
anti-Disabled antibodies reliably co-precipitated Trio, both from
adult (Fig. 6A, lane 4, top panel) and embryo extracts,
suggesting that Trio and Disabled are indeed found in common
complexes in vivo.
Fig. 4. E(spl)mδ is not activated during Notch-dependent guidance of CNS and ISNb pioneer axons. Wild type embryos bearing a Notch reporter transgene,
E(spl)mδ-lacZ, were double-labelled with mAb22C10 and anti-β-gal to examine the CNS pioneer neurons dMP2 and vMP2 (A–C, stage 12.0), or with anti-Fasciclin 2
and anti-β-gal to examine the ISNb pioneer, RP3 (D–F, stage 15). Merged signals are shown in panels A, D; separated channels in panels B, E (anti-neuron signal, red)
and C, F (anti-β-gal, green), respectively. Growth cones are indicated with orange arrows, cell body position with yellow arrows.
Fig. 5. Overexpression of Disabled interacts genetically with Notch in ISNb
pathfinding. Notchts1 embryos were generated that did, or did not, overexpress
wildtype Disabled under control of elav-GAL4. Embryos were temperature-
shifted, fixed and assayed for ISNb patterning as for the experiment of Fig. 3.
Thick vertical bars report the percentage of hemisegments in which ISNb axons
bypassed the first choice point; thin lines represent SEM.
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Previous studies have led us to speculate that the Abl
tyrosine kinase and its associated accessory factors might define
an alternate, ‘non-canonical’, Su(H)-independent signaling
pathway for the receptor Notch (Crowner et al., 2003; Giniger,
1998). The data reported here provide strong support for this
hypothesis. In extracts of wild type Drosophila, Notch is
associated with Disabled and Trio, two proteins that have been
associated with the action of Abl tyrosine kinase. The functions
of Notch in axon growth and guidance are likely to be executed
by these complexes of Notch with Disabled and Trio, and not by
its association with Su(H), since deletion of the Disabled
binding site from Notch significantly impairs the axon
patterning function of the receptor, whereas the Su(H) binding
sites are largely dispensable for this process. Moreover, we
describe two other Notch derivatives that are still capable of
executing the axon patterning functions of the receptor despite
being completely inactive for specifying Notch-dependent cell
fates. Taken together with previous data demonstrating that the
genetic interaction of Notch with multiple Abl pathway
components is required specifically for Notch-dependent axon
patterning, these data provide a molecular picture of a Notch
signaling machinery that is distinct from the well-established
mechanism by which a proteolytic fragment of Notch enters the
nucleus to directly control transcription of Su(H)-dependent
target genes.
The key genetic data in favor of our hypothesis stem from the
targeted construction of Notch derivatives that preferentially
impair either the canonical, cell fate function of the receptor or
its Abl-dependent axon patterning function, respectively.
Deletion of the Su(H) binding sites from Notch progressively
Fig. 6. Co-immunoprecipitation of Notch with Disabled and Trio from wild type Drosophila lysates. Total extracts were made from wild type embryos (B) or adult
heads (A, C) and subjected to immunoprecipitation with the indicated antibodies. Precipitates were separated by SDS-PAGE, immunoblotted with the indicated
antibodies and visualized by ECL. Small circles indicate bands attributable to the primary antibodies. Molecular weight markers (in kilodaltons) are indicated on the
right in each panel. (A) Immunoprecipitations of wild type head extract with either anti-Notch (lane 3) or with polyclonal anti-Disabled (lane 4). Probing with anti-Trio
(top panel) detects the ca. 250 kDa form of Trio in both Notch and Disabled immunoprecipitates (arrow; compare anti-Trio IP and input, lanes 1 and 2, respectively). A
smaller Trio variant (ca. 120 kDa, arrowhead) comigrates with a prominent antibody band, so we can not determine whether it is also present in the
immunoprecipitates. A very small non-specific background of Trio was often detected in control anti-Islet immunoprecipitates (lane 5), but quantification (Image J)
demonstrated that the Trio signal observed in anti-Disabled and anti-Notch IPs was more than 4× above this background level. Probing the same samples with anti-
Notch (middle panel) detects full length Notch in the input and in the anti-Notch IP (lanes 2, 3) and also co-precipitated with polyclonal anti-Disabled (lane 4). Probing
these samples with anti-Disabled (bottom panel) detects Disabled protein only in the input and in the anti-Disabled IP (lanes 2, 4). mAB P6E11 is not sufficiently
sensitive to test for Disabled protein in anti-Notch IPs. (B) Immunoprecipitation of wild type embryo extract with anti-Notch (lane 2) or monoclonal anti-Disabled (lane
4) followed by Western blotting with anti-Notch antibody detects full-length Notch (arrow), whereas immunoprecipitation with a control IgG (anti-Islet, lane 3) does
not. Input lysate is shown for comparison (lane 1). (C) Immunoprecipitations from adult head extract were assayed by Western blotting with anti-Notch. Notch protein
(arrow) is readily detectable in anti-Trio immunoprecipitates of wild type extract (lane 4) but not in immunoprecipitates with a control antibody (anti-Islet, lane 3).
Input extracts (lane 1) and anti-Notch IP (lane 2) are shown for comparison.
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neurogenesis, but has only limited effect on growth of CNS
longitudinal axons, and no detectable effect on Notch-
dependent defasciculation of ISNb motor axons. In contrast,
deletion of the Disabled binding site substantially reduces the
axon patterning activity of Notch (30–40%, depending on the
assay), while having no effect on cell fate function beyond what
can be accounted for by the known Su(H) binding site within
the deletion. The properties of these complementary Notch
mutants argue for the action of a qualitatively different Notch
mechanism in axon patterning. Further supporting this hypoth-
esis is the observation that Notch co-precipitates from wildtype
fly extracts with two cytoplasmic signaling proteins, the Abl
cofactor, Trio and the adaptor protein, Disabled, potentially
providing a molecular machinery to account for our phenotypic
data. In principle, a good way to further test the basis of theNotch axonal phenotype would be to examine a disabled
mutant, but unfortunately no such mutants are currently
available (Liebl et al., 2003). The phenotype of a trio mutant,
on the other hand, is consistent with the results documented here
(Bateman et al., 2000; Hakeda-Suzuki et al., 2002; Liebl et al.,
2000). The zygotic mutant phenotypes of trio are somewhat
subtle, evidently because of persistence of maternally-provided
trio RNA and protein, but they include defects in some of the
CNS longitudinal axons that are affected in Notchts embryos, as
well as defects in ISNb motor axon guidance, while trio has not
been reported to produce any Notch-like defects in cell fate
(Bateman et al., 2000; Liebl et al., 2000).
While deletion of the Disabled binding region of Notch
clearly reduces the axonal activity of the protein, substantial
residual activity still remains. In the case of Su(H), residual
activity of a Notch mutant lacking all in vitro Su(H) binding
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ankyrin repeats that requires the cofactor, Mastermind (Nam et
al., 2006; Wilson and Kovall, 2006; Wu et al., 2000). By
analogy, perhaps Disabled can also associate with Notch via a
second site that requires a cofactor present in vivo. Consistent
with this idea, preliminary biochemical experiments hint that
the RamΔA mutation does not wholly ablate recruitment of
Disabled and Trio in vivo (MLG and EG, unpublished
observations), though current reagents do not allow us to assess
this rigorously. If so, the ankyrin/cdc10 repeat region would be
a plausible candidate for a secondary site of association.
Experiments in Fig. 1 show that the ankyrin repeats, together
with the C-terminal portion of the Ram region, contribute
substantially to Notch-dependent axon patterning. Since our
experiments clearly show that the canonical Notch signaling
pathway is dispensable for axonal function, the axonal
requirement for this portion of the protein cannot be traced to
its function in canonical signaling, and a contribution to
formation or activity of Notch/Abl pathway complexes would
offer the simplest explanation.
To date, the role of Disabled in the Abl signaling pathway
has been difficult to establish due to the lack of loss-of-
function Disabled mutant alleles. The placement of Disabled in
the Abl pathway was based initially largely upon the
observation that modest overexpression of Disabled suppressed
both the embryonic lethality and morphological defects
produced by genetic interactions of Abl with its accessory
genes Nrt and Fax (Gertler et al., 1993; Liebl et al., 2003). Our
data now show that deletion of the Disabled binding region of
Notch specifically impairs a Notch function, axon patterning,
that depends on the interaction of Notch with multiple Abl
pathway components (Figs. 2 and 3; Crowner et al., 2003;
Giniger, 1998). Moreover, GAL4-driven overexpression of
Disabled modifies the Notch ISNb phenotype in the same way
as do other treatment that enhance Abl signaling, such as
overexpression of Abl or reduction of enabled (Fig. 5; Crowner
et al., 2003). Thus, these data provide further support for
association of Disabled with the Abl signaling pathway, though
a definitive demonstration awaits the generation and character-
ization of a disabled mutation.
The presence of Trio in Notch complexes suggests that
Rho family GTPases, particularly Rho and Rac, are good
candidates for a downstream readout of Notch/Abl signaling
(Hakeda-Suzuki et al., 2002; Luo, 2000; Newsome et al.,
2000). Consistent with this we have observed dominant
genetic interactions of Notch with mutations in the three
Drosophila Rac genes, but not, for example, with Cdc42 (EG,
unpublished observations). Such a readout would make sense
in the context of the effects of Notch on growth cone
guidance and would be consistent with previous studies of
Drosophila Trio (Hakeda-Suzuki et al., 2002; Newsome et
al., 2000) and mammalian Abl (Renshaw et al., 1996). It is
interesting to note that identification of Rac as an effector of
Notch/Abl signaling might suggest the possibility of Notch/
Abl signaling having a non-Su(H) nuclear component in some
developmental contexts in addition to its cytoskeletal targets
(Hall, 2005; Lim et al., 1996). Rho family GTPases typicallyhave multiple downstream targets, including nuclear gene
regulation in addition to cytoskeletal structure and dynamics
(Luo, 2000).
The key step in canonical Notch signaling is the
proteolytic cleavage of the receptor by γ-secretase to release
the active, intracellular moiety of the molecule, NICD. Does
γ-secretase also play a role in Notch/Abl signaling? Since we
find Disabled and Trio associated with full-length Notch prior
to cleavage, and since Notch/Abl signaling in the growth cone
presumably targets the cortical actin cytoskeleton, one
possibility is that γ-secretase cleavage terminates the Notch/
Abl signal by separating the receptor-bound complex from
membrane-tethered components of the pathway such as Abl
kinase and Rho GTPases. Alternatively, in contexts such as
ISNb, perhaps displacement of Disabled and Trio away from
the membrane is part of the mechanism by which Notch
antagonizes Abl pathway activity. Moreover, while proteolytic
activity is the most apparent function of γ-secretase there
have been suggestions that the complex may also have a
separate function in Notch trafficking, aside from cleavage. If
so, this activity could modulate Notch/Abl signaling inde-
pendent of any role for protease cleavage. Clearly, additional
experiments will be necessary to assess the various possible
models.
Is the interaction of Notch with Abl pathway proteins
limited to just a few Drosophila growth cones, or is it of
more general biological significance? Our ability to detect
Notch complexes with Disabled and Trio in extract of whole
embryos argues for the latter, as does the strong phyloge-
netic conservation of all the components of the pathway.
Good candidates for potential Notch/Abl-dependent processes
are provided by those developmental contexts in which non-
Su(H) Notch signaling has been proposed previously. In
Drosophila, these include organization of actin structure at
the D/V boundary of the developing wing (Major and Irvine,
2005); in mammals, they include myogenesis and B-cell
development, as well as a ligand-stimulated cytoplasmic
signaling process of Notch that is essential for the survival
of mouse neural stem cells and human embryonic stem cells
(Androutsellis-Theotokis et al., 2006; Ordentlich et al., 1998;
Shawber et al., 1996).
Axon guidance and classic lateral inhibition seem to
represent limit cases in which the Notch signal is largely
transduced selectively through either the Abl pathway or the
Su(H) pathway, respectively. It seems likely, however, that
in each case both pathways make some contribution to
Notch function: deletion of Su(H) binding sites does have
some deleterious effect on growth of CNS longitudinal
axons (Fig. 2), while mutation of Abl and Nrt cause small
but reproducible decreases in the efficacy of the classic
Notch function that discriminates the identities of sibling
cells (Giniger, 1998; EG, unpublished observations). Perhaps
two parallel Notch signals, one through the canonical Su(H)
pathway and the other mediated by the Notch/Abl interaction,
can be used in concert to provide a richer nuclear readout, or
to coordinate nuclear gene regulation with cortical properties
such as cytoskeletal structure and cell adhesion. It will be of
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Notch, such as dendritic patterning (Berezovska et al., 1999;
Redmond et al., 2000; Sestan et al., 1999) or oncogenesis
(Raafat et al., 2007), reflect more balanced contributions both
from canonical Notch signaling and from the Notch/Abl
pathway.
Experimental procedures
Genetics, Drosophila stocks and temperature-shift protocols
Rescue of Notch axonal and cell fate defects by UAS-Notch transgenes was
performed as described previously (Crowner et al., 2003; Giniger, 1998; Le Gall
and Giniger, 2004), with the modification that for the experiment of Fig. 2, assay
of CNS axon extension employed the following temperature-shift protocol to
improve the precision of quantification: embryos were collected 4 h at 18 °C;
aged 7 h, 18 °C, shifted 7 h 45′ (32 °C), then fixed. To induce neurogenic defects
in Notchts1, embryos were collected 6 h (18 °C), shifted 10 h (32 °C) and then
fixed. UAS-NotchΔcdc10 and UAS-NotchΔEGF10–12 flies were from A. Martinez-
Arias (Zecchini et al., 1999), UAS-NotchECN was from M. Muskavitch
(Jacobsen et al., 1998). The UAS-NotchΔ2155 transgene was obtained from C.
Wesley (Wesley and Saez, 2000) and transformant lines were generated by
injection into w1118. UAS-Disabled was from D. Van Vactor (Wills et al., 1999).
All other mutants and UAS transgenes have been described previously
(Giniger, 1998; Le Gall and Giniger, 2004) except UAS-NotchΔRamA. For this
construct, a deletion of Notch codons T1766–R1801 was generated by PCR
and reconstructed into full-length UAS-Notch as described for other
juxtamembrane derivatives (Le Gall and Giniger, 2004).
Antibody methods
Embryos for immunocytochemistry were collected, fixed and stained by
standard methods (Bodmer and Jan, 1987). Detection was performed using
biotinylated secondary antibodies and the Vectastain Elite tertiary reagent
(Vector Labs), with DAB development. Embryos were examined either as
whole-mounts in JB4 embedding medium or as filet preps in 80% glycerol.
Fluorescence microscopy was performed on filleted samples mounted in
FluoroGuard (BioRad), using a Zeiss AxioImager and deconvolution of the
resulting image stacks.
Antibodies, their sources and the dilutions used were as follows. For
embryo immunostaining, anti-Fasciclin 2 (mAb 1D4, 1:150), anti-Sxl (mAb
M114; 1:50), mAb 22C10 (1:25) and rat anti-Elav (mAb 7E8A10; 1:20)
were obtained from the Developmental Studies Hybridoma Bank; rabbit
anti-β-galactosidase (1:10,000) was from Cappel. For biochemical experi-
ments, immunoprecipitations were performed using 1–10 μg of specific
antibody per sample, and Western blotting was performed using 10–50 μg
specific antibody per 10 ml probe solution. Anti-Notch (C17.9C6), anti-islet
(mAb40.3A4) and anti-β-tubulin (E7) were from the DSHB. Rabbit anti-
Trio B6 and mouse anti-Trio (mAb 9A4) were gifts from C. Hama
(Awasaki et al., 2000). A high-concentration stock of purified mAb9A4 was
generated by the Antibody Production Facility of the Fred Hutchinson
Cancer Research Center, using cells provided by Dr. Hama. Non-immune
mouse IgG, rabbit-anti-mouse IgG, and all secondary antibodies were from
Jackson ImmunoResearch.
Antibodies against Drosophila Disabled protein were prepared as follows.
The coding sequence for a fragment of Disabled corresponding to the amino-
terminal 2/3 of the protein (from the PTB domain up to an EcoRI site at nt5868
in the numbering of Gertler et al., 1993) was subcloned in frame into pGEX2T to
generate a GST fusion construct, and into pRSET A to generate a His-tagged
construct. After transformation of expression constructs into Escherichia coli,
tagged protein was grown up at room temperature and purified on glutathione
beads or nickel beads, respectively, by standard methods. Several polyclonal
anti-Disabled antisera were prepared by Dr. Liz Wayner of the FHCRC
Antibody Development Facility by injection of either fusion protein into mice,
using standard protocols. Two mice that gave ELISA-positive bleeds after
injection with the His-tagged immunogen were further used to generatehybridomas; these were screened by ELISA, Western blotting, immunopreci-
pitation and whole mount embryo staining. mAb P4D11 was found to
immunoprecipitate a set of species with the published characteristics of
Disabled from extracts of wild type Drosophila; mAb P6E11 recognized on a
Western blot a family of high-molecular weight species of a size consistent with
Disabled, and which were absent from extract of embryos deleted for the
Disabled locus (Supplementary Fig. S-1). Both antibodies also labeled (albeit
with some nonspecific background, especially for mAb P4D11) a pattern of
tissues in whole mount embryos consistent with the Disabled expression pattern
and absent from dab-deficient embryos. A high concentration stock of mAb
P6E11 ascites was prepared by Maine Biotechnology.
Quantification of phenotypes
Phenotypes were quantified as follows:
For CNS longitudinal axons, Fasciclin 2-labelled embryos were examined
either as filet preps, or in appropriately oriented wholemounts, and the number of
thoracic and abdominal hemisegments in which there was a complete or nearly
complete disconnection between successive segments was counted and
expressed as a percentage of the total. A “nearly complete” disconnection was
defined as one in which the residual connection between hemisegments consisted
of a single Fasciclin 2-positive axon bundle with less then ∼1/5 the staining
intensity of a wildtype fascicle. In a single experiment, either filet preps or whole
mounts were quantified; quantitative data were not compared between different
kinds of preparations. Note that slightly different temperature-shift protocols
were employed for the experiments of Fig. 1 vs. Fig. 2 (see above) so expressivity
per hemisegment should not be compared between these two experiments.
ISNb defasciculation was assayed in abdominal segments A2–A7 in filet
preps of Fasciclin 2-labelled embryos (Crowner et al., 2003). A hemisegment
was scored as an aberrant “bypass” hemisegment if at least one Fasciclin 2-
positive ISNb axon failed to defasciculate from the ISN and project internally at
the wild type choice point, immediately ventral to muscle 28, and instead
projected external to muscle 28. The fraction of bypass hemisegments was
scored in greater than 100 hemisegments of each of at least three separate
experiments. Reproducibility (SEM) was ±3% for this assay.
Notch neurogenic phenotypes were quantified by counting the number of
Elav-immunoreactive nuclei in the dorsal cluster of sensory neurons in




Lysis buffer for both embryo lysates and head lysates was 25 mM Tris (pH
7.5), 100 mMNaCl, 0.5 mMDTT, 0.5% NP-40 (v:v), 10% glycerol (v:v), 1 mM
PMSF+a 1:100 dilution of a cocktail containing 1 mg/ml leupeptin, 1 mg/ml
pepstatin, 2 mg/ml aprotinin and 10 mg/ml benzamidine (prepared in DMSO).
For whole embryo lysates, embryos were collected on grape juice plates 18–24 h
at 25 °C. Embryos were harvested with 0.7% NaCl/0.3% Triton X-100,
dechorionated with 50% bleach, washed with NaCl/Triton and transferred to an
ice-cold Dounce homogenizer. Embryos were then washed twice with cold H2O
and once with cold lysis buffer. Embryos were suspended with 3 volumes of
lysis buffer and lysed with 25 strokes of an ice-cold A pestle, followed by 25
strokes with a cold B pestle. Embryo lysate was transferred to microfuge tubes
and centrifuged at 15,000×g for 10′ at 4 °C. The supernatent was removed to
fresh tubes and either used immediately or frozen in aliquots on dry ice and
stored at −80 °C.
For head lysates, flies of the appropriate genotype were anaesthetized with
CO2, transferred to a Falcon tube and flash frozen with liquid N2. Immediately
after the nitrogen boiled off, the flies were vortexed vigorously to shake off
heads and appendages (taking care to keep the flies frozen), and heads were
isolated away from bodies and legs with appropriate minisieves (Fisher): heads
are passed by the #25 mesh but retained by the #45 mesh. Sieve assembly was
prechilled with liquid N2 and kept cold during the separation process. Isolated
heads were transferred to a puddle of liquid N2 in a prechilled agate mortar,
ground to a fine powder with a chilled pestle, and transferred to an ice-cold
Dounce. Ice-cold lysis buffer was added (using 1/5 the starting volume of whole
flies, corresponding to ∼3× the volume of isolated heads) and the powder was
566 M. Le Gall et al. / Developmental Biology 313 (2008) 556–567homogenized with 25 strokes each of the A pestle and B pestle, avoiding
excessive frothing of the lysate. Lysate was clarified, frozen and stored as for
embryo lysates.
Immunoprecipitation
Protein A sepharose beads (Amersham) were blocked with lysis buffer
containing 0.5% BSA, prebound with Rb anti-mouse IgG (10 μg Rb anti-mouse
per 10 μl of beads), washed 2×, bound with the appropriate primary antibody,
and washed 2×. Extract was thawed on ice, and 10 μl of protein A/Rb anti-
mouse beads was added per IP sample (150 μl of extract, diluted to 300 μl final
volume with lysis buffer) for pre-clearing. Fresh 0.2 mM PMSF was added to
thawed lysate prior to clearing. Sample was rocked at 4 °C for 1 h, then cleared
by centrifugation at 15,000×g, 10′, 4 °C. Supernatent was removed and used
immediately for co-immunoprecipitation. Beads bearing the appropriate primary
antibody (10 μl) were added per IP sample and rocked at 4 °C for 90′. Beads
were spun down for 5ʺ, unbound material was removed, and the beads were
washed 4× with lysis buffer. Beads were then boiled in 20 μl Laemmli sample
buffer. Samples were analyzed by SDS-PAGE and Western blotting. ECL
detection was used, employing the Pierce SuperSignal West Pico or Femto
reagents, or the Amersham ECL Advance system.
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